Showing 371-380 of 739 results for "".
Rhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhofade-approved-sun-leaves-acne-behind-radiesse-turns-10/18552/The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking upValeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.A Dermatologist’s Guide to LinkedIn Marketing
https://practicaldermatology.com/topics/practice-management/a-dermatologists-guide-to-linkedin-marketing/23830/Understanding unique features of the social network allows practices to optimize their brand engagement.Teledermatology Update: Restrictions Lifted Due to COVID-19
https://practicaldermatology.com/topics/practice-management/teledermatology-update-restrictions-lifted-due-to-covid-19/23256/Easing of guidelines may allow more practices to add teleconsults.South Beach Bums
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/south-beach-bums/19707/Today's technology allow for buttock lifting. Key is to identify the right candidates, set expectations, and use the right devices, says Manjula Jegasothy, MDDiet and AD: Can We Stop Leaky Skin?
https://practicaldermatology.com/topics/atopic-dermatitis/diet-and-ad-can-we-stop-leaky-skin/19545/New evidence elucidates the link between diet, atopic dermatitis, and food allergy and may point to opportunities to protect the skin in order to prevent allergy and AD. Peter Lio, MD reviews the latest science.Low Tech, High Impact
https://practicaldermatology.com/topics/practice-management/low-tech-high-impact/18435/Two-way communication: It could be improve efficiency and allow for better communication within the practice. Suneel Chilukuri, MD of Refresh Dermatology explains.Utilizing different Social Media Platforms for any practice
https://practicaldermatology.com/topics/practice-management/utilizing-different-social-media-platforms-for-any-practice/19094/Social Media allows for a whole new stepping stone when implementing the various forms into your marketing efforts. This webinar discusses the different social media platforms available and how to utilize them in your social media marketing efforts to it's fullest capacity. When implemented and usedChanging Approaches to Diagnosis and Research: DermTech's Contributions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/changing-approaches-to-diagnosis-and-research-dermtechs-contributions/20137/John Dobak, MD, President/CEO of DermTech discusses the addition of the company's melanoma test to the National Comprehensive Cancer Network guidelines. He talks about the future of clinical trials, especially the role of genomics for identifying trial participants and allowing more precise analysisAnti-OX40 Ligand Antibody Trials
https://practicaldermatology.com/series/updates-atopic-dermatitis/anti-ox40-ligand-antibody-trials/29531/Lead study author Stephan Weidinger, MD, PhD, Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, discusses the phase 2b STREAM-AD trial, evaluating amlitelimab in adult patients with moderate-to-severe atopic dermatitis.